The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Klukina L.A.

I.M. Sechenov First Moscow State Medical University

Sosnova E.A.

Sechenov First Moscow State University (Sechenov University)

Ischenko A.A.

Medical and Rehabilitation Center

Modern ideas about oncological aspects of ovulation induction in assisted reproductive technology programs in carriers of BRCA1/2 gene mutations

Authors:

Klukina L.A., Sosnova E.A., Ischenko A.A.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2022;22(4): 47‑54

DOI: 10.17116/rosakush20222204147

Views: 1538

Downloaded: 22

Download PDF (RU)
Contact the author
Table of contents

MODERN IDEAS ABOUT ONCOLOGICAL ASPECTS OF OVULATION INDUCTION IN ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMS IN CARRIERS OF BRCA1/2 GENE MUTATIONS
MODERN IDEAS ABOUT ONCOLOGICAL ASPECTS OF OVULATION INDUCTION IN ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMS IN CARRIERS OF BRCA1/2 GENE MUTATIONS

To cite this article:

Klukina LA, Sosnova EA, Ischenko AA. Modern ideas about oncological aspects of ovulation induction in assisted reproductive technology programs in carriers of BRCA1/2 gene mutations. Russian Bulletin of Obstetrician-Gynecologist. 2022;22(4):47‑54. (In Russ.)
https://doi.org/10.17116/rosakush20222204147

Подписка 2025-2 (Russian Bulletin of Obstetrician-Gynecologist)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Correlation depe­ndence of tissue inhi­bitor of meta­lloproteinase-1 levels and follicular fluid morphology in patients with combined (uterine myoma and endo­metriosis) infe­rtility in the ART-programs. Russian Bulletin of Obstetrician-Gynecologist. 2024;(4):21-28
The impact of arti­ficial inte­lligence on double reading of mammograms. Russian Journal of Preventive Medi­cine. 2024;(5):32-37
Reco­nstructive plastic surgery in combined treatment of breast cancer: predictive risk factors of complications and reco­nstruction failure. P.A. Herzen Journal of Onco­logy. 2024;(3):13-19
Targeted lymphadenectomy with sentinel lymph node biopsy in patients with breast cancer cT1-3N1M0 after neoadjuvant poly­chemotherapy. P.A. Herzen Journal of Onco­logy. 2024;(3):73-78
Breast cancer: types of implantable mate­rials for replacement of postresection defe­cts. P.A. Herzen Journal of Onco­logy. 2024;(3):85-89
Intrathecal chemotherapy for leptomeningeal meta­stases in patients with breast cancer. Burdenko's Journal of Neurosurgery. 2024;(3):31-37
Assi­sted reproductive technologies and the risk of placenta accreta. Russian Journal of Human Reproduction. 2024;(3):43-49
Expression of transferrin rece­ptor 1 and β1-integrins correlates with estrogen rece­ptor status and immune infi­ltration in breast cancer. Russian Journal of Archive of Pathology. 2024;(4):23-30
Indo­cyanine green is an inte­gral part of breast reco­nstructive surgery using perforator flaps. Piro­gov Russian Journal of Surgery. 2024;(8):34-40
Leading trends in breast cancer inci­dence in the Repu­blic of Crimea. P.A. Herzen Journal of Onco­logy. 2024;(4):42-47

Mutations in the BRCA1/2 genes are an independent and fundamental risk factor for breast cancer and ovarian cancer. The specifics of the effect of infertility treatment on the risk of developing cancer in carriers of mutations in the BRCA1/2 genes remain unclear and require a comprehensive study. In this review, we analyze published studies on the possible relationship between infertility treatment and the risk of ovarian and breast cancer in carriers of the BRCA1/2 mutation.

Keywords:

breast cancer
ovarian cancer
ovulation stimulation
assisted reproductive technologies
BRCA1/BRCA2 mutations

Authors:

Klukina L.A.

I.M. Sechenov First Moscow State Medical University

Sosnova E.A.

Sechenov First Moscow State University (Sechenov University)

Ischenko A.A.

Medical and Rehabilitation Center

Received:

16.11.2021

Accepted:

16.12.2021

List of references:

  1. Cetin I, Cozzi V, Antonazzo P. Infertility as a cancer risk factor — a review. Placenta. 2008;1-9.  https://doi.org/10.1016/j.placenta.2008.08.007
  2. Korneeva IE, Koval’chuk AI. Prevention of premature peak of luteinizing hormone by gestagen in the modified protocol of ovarian stimulation of assisted reproductive technology programs. Akusherstvo i ginekologiya. 2020;11:39-43. (In Russ.). https://doi.org/10.18565/aig.2020.11.39-43
  3. Meirow D, Schenker JG. The link between female infertility and cancer: epidemiology and possible aetiologies. Hum Reprod. 1996;2:1:63-75.  https://doi.org/10.1093/humupd/2.1.63
  4. Attia A. EBM in action: Does ovulation induction increase the risk of ovarian cancer? Middle East Fertil Soc J. 2006;11:2:135-139. 
  5. Fathalla MF. Incessant ovulation: a factor in ovarian neoplasia? Lancet. 1971;2:163.  https://doi.org/10.1016/s0140-6736(71)92335-x
  6. Henderson BE, Ross R, and Bernstein L. Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation Award Lecture. CANCER RESEARCH. 1988;48:246-253. 
  7. Burdette JE, Kurley SJ, Kilen SM, Mayo KE, Woodruff TK. Gonadotropin-induced superovulation drives ovarian surface epithelia proliferation in CD1 mice. Endocrinology. 2006;147:2338-2345. https://doi.org/10.1210/en.2005-1629
  8. Reubinoff BE, Har-El R, Kitrossky N, Friedler S, Levi R, Lewin A, Chevion M: Increased levels of redox-active iron in follicular fluid: a possible cause of free radical-mediated infertility in betathalassemia major. Am J Obstet Gynecol. 1996;174:914-918.  https://doi.org/10.1016/s0002-9378(96)70325-3
  9. Malins DC, Haimanot R. Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res. 1991;51:19:5430-5432.
  10. Krishna Dasari, Chikezie O Madu and Yi Lu. The role of oxidative stress in cancer. NACS.000584. 2020;4:2:350-355.  https://doi.org/10.31031/NACS.2020.04.000585
  11. Obaka K, Morland SJ, Watson RH, Hitchcock A, Chenevix-Trench G, Thomas EJ, Campbell IG. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res. 1998;58:10:2095-2097.
  12. Babaeva NA, Ashrafyan LA, Antonova IB, Aleshikova OI, Ivashina SV. The role of hormonal disorders in the carcinogenesis of tumors of the female reproductive system. Zhurnal dlya nepreryvnogo meditsinskogo obrazovaniya vrachei. 2017;1:76-82. (In Russ.).
  13. Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, BRCA1 and BRCA2 Cohort Consortium; McGuffog L, Evans DG, Barrowdale D, Fros D t, Adlard J, Kai-Ren Ong, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker J-P, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, SchmutzlerRK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan S-A, Machackova E, Foretova L, Yen Y Tan, Singer CF, Olah E, Gerdes A-M, Arver B, Olsson H. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:23:2402-2416. https://doi.org/10.1001/jama.2017.7112
  14. Kutluk Oktay, Ja Yeon Kim, David Barad, Samir N Babayev. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol. 2010;28:2:240-244.  https://doi.org/10.1200/JCO.2009.24.2057
  15. Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van de Vijver MJ, Venter D, Freeman A, Antoniou A, McGuffog L, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BAJ, Futreal PA, Peto J, Stoppa-Lyonnet D, Yves-Jean Bignon, Struewing JP, D Timothy Bishop, Klijn JGM, Devilee P, Cornelisse CJ, Lasset C, Lenoir G, Barkardottir RB, Egilsson V, Hamann U, Jenny Chang-Claude, Sobol H, Weber B, Easton DF, and Stratton MR. The Pathology of Familial Breast Cancer: Histological Features of Cancers in Families Not Attributable to Mutations in BRCA1 or BRCA2. Clinical Cancer Research. 2000;6:782-789. 
  16. Flippo-Morton T, Walsh K, Chambers K, Amacker L North, White B, Sarantou T, Boselli DM, White RL Jr. Surgical decision making in the BRCA-positive population: institutional experience and comparison with recent literature. Breast J. 2016;22:1:35-44. 
  17. Kotsopoulos J, Librach CL, Lubinski J, Gronwald J, Kim-Sing C, Ghadirian P, Lynch H, Møller P, Foulkes W, Randall S, Manoukian S, Pasini B, Tung N, Ainsworth P, Cummings S, Sun P, Narod S. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case—control study. Cancer Causes Control. 2008;19:10:1111-1119. https://doi.org/10.1007/s10552-008-9175-0
  18. Derks-Smeets IAP, Schrijver LH, de Die-Smulders CD, Tjan-Heijnen V, van Golde RV, Smits L, Caanen B, van Asperen CV, Ausems M, Collee M, van Engelen K, Kets C, van der Kolk L, Oosterwijk J, van Os TV, Rookus M, van Leeuwen FV, García EGG. Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers. Br J Cancer. 2018;119:3:357-363.  https://doi.org/10.1038/s41416-018-0139-1
  19. Perri T, Naor-Revel Sh, Eliassi-Revivo P, Lifshitz D, Friedman E, Korach J. Fertility treatments and breast cancer risk in Jewish Israeli BRCA mutation carriers. Fertil Steril. 2021;116:2:538-545.  https://doi.org/10.1016/j.fertnstert.2021.02.030
  20. Perri T, Lifshitz D, Sadetzki S, Oberman B, Meirow D, BenBaruch G, Friedman E, Korach J. Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers. Fertil Steril. 2015;103:5:1305-1312. https://doi.org/10.1016/j.fertnstert.2015.02.011
  21. Gronwald J, Glass, K Rosen B, Karlan B, Tung N, Neuhausen S, Møller P, Ainsworth P, Sun P, Narod S, Lubiński J, Kotsopoulos J. Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. Fertil Steril. 2016;105:3:781-785.  https://doi.org/10.1016/j.fertnstert.2015.11.034
  22. Burkman R, Tang M, Malone K, Marchbanks P, McDonald JA, Folger S, Norman S, Strom B, Bernstein L, Ursin G, Weiss L, Daling J, Simon M, Spirtas R. Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human development Women’s Contraceptive and Reproductive Experiences Study. Fertil Steril. 2003;7:844-51.  https://doi.org/10.1016/s0015-0282(02)04950-6
  23. Brinton L, Scoccia B, Moghissi K, Westhoff C, Althuis M, Mabie J, Lamb E. Breast cancer risk associated with ovulation stimulating drugs. Hum Reprod. 2004;19:9:2005-2013. https://doi.org/10.1093/humrep/deh371
  24. van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M, Laven J, Jansen C, Helmerhorst F, Cohlen B, Willemsen W, Smeenk J, Simons A, van der Veen F, Evers J, van Dop PV, Macklon N, Burger C. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod. 2011;26:3456-3465. https://doi.org/10.1093/humrep/der322
  25. Lerner-Geva L, Keinan-Boker L, Blumstein T, Boyko V, Olmar L, Mashiach S, Rabinovici J, Potashnik G, Lunenfeld E, Schenker J, Shushan A, Fishman A, Cohen I, Vagman I, Lunenfeld B. Infertility, ovulation induction treatments and the incidence of breast cancer-a historical prospective cohort of Israeli women. Breast Cancer Res Treat. 2006;100:2:201-212.  https://doi.org/10.1007/s10549-006-9238-4
  26. Louise A. Brinton, Britton Trabert, Varda Shalev, Eitan Lunenfeld, Tal Sella, Gabriel Chodick. In vitro fertilization and risk of breast and gynecologic cancers: A retrospective cohort study within the Israeli Maccabi Healthcare Services. Fertil Steril. 2013;99:5:1189-1196. https://doi.org/10.1016/j.fertnstert.2012.12.029
  27. van den Belt-Dusebout AW, Spaan M, Lambalk C, Kortman M, Laven J, van Santbrink EJV, van der Westerlaken LVD, Cohlen B, Braat D, Smeenk J, Land J, Goddijn M, van Golde RV, van Rumste MV, Schats R, Józwiak K, Hauptmann M, Rookus M, Burger C, van Leeuwen FV. Ovarian stimulation for in vitro fertilization and long-term risk of breast cancer. JAMA. 2016;316:3:300-312.  https://doi.org/10.1001/jama.2016.9389
  28. Lalwani N, Prasad SR, Vikram R, Shanbhogue A, Huettner P, Fasih N. Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics. 2011;31:625-646.  https://doi.org/10.1148/rg.313105066
  29. Lyubchenko LN, Bateneva EI, Abramov IS, Emel’yanova MA, Budik YuA, Tyulyandina AS, Krokhina OV, Vorotnikov IK, Sobolevskii VA, Nasedkina TV, Portnoi SM. Hereditary breast and ovarian cancer. Zlokachestvennye opukholi. 2013;2:6:53-61. (In Russ.).
  30. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett L, Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:5182:66-71.  https://doi.org/10.1126/science.7545954
  31. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rices C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Tonin P, Bishop D, Spurr N, Ponder B, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir RB, Easton D, Bentley D, Futreal PA, Ashworth A, Stratton M. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:6559:789-792.  https://doi.org/10.1038/378789a0
  32. Bochkov NP, Ginter EK, Puzyrev VP. Hereditary diseases: national guidelines. M.: GEOTAR-Media; 2013. (In Russ.).
  33. Williams MJ, Sottoriva A, Graham TA. Measuring clonal evolution in cancer with genomics. Annu Rev Genomics Hum Genet. 2019;20:309-329.  https://doi.org/10.1146/annurev-genom-083117-021712
  34. Nussbaum RL, McInnes RR, Willard HF, Hamosh A. Genetics in medicine. Elsevier. 2007;358-362. 
  35. Chesire DM, Dunn TA, Eving CM, Ewing CM, Luo J, Isaacs WB. Identification and aryl hydrocarbon receptor. Cancer Res. 2004;64:7:2523-2533. https://doi.org/10.1158/0008-5472.can-03-3309
  36. Lyubchenko LN, Bateneva EI. Medical and genetic counseling and DNA diagnostics for hereditary predisposition to breast cancer and ovarian cancer. Posobie dlya vrachei. M.: IG RONC; 2014;64. (In Russ.).
  37. Cazzaniga M, Bonanni B. Prevention of ER-negative breast cancer: where do we stand? Eur J Cancer Prev. 2012;21:2:171-181.  https://doi.org/10.1097/CEJ.0b013e32834c9c26
  38. Brzezinski A, Peretz T, Mor-Yosef S, Schenker J. Ovarian stimulation and breast cancer: Is there a link? Gynecol Oncol. 1994;52:292-295.  https://doi.org/10.1006/gyno.1994.1051
  39. Pappo I, Lerner-Geva L, Halevy A. The possible association between IVF and breast cancer incidence. Ann Surg Oncol. 2008;15:4:1048-1055. https://doi.org/10.1245/s10434-007-9800-2
  40. Mitsudomi T, Yatabe Y. Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer. Cancer Sci. 2007;98:12:1817-1824. https://doi.org/10.1111/j.1349-7006.2007.00607.x
  41. Ramus SJ, Gayther SA. The contribution of BRCA1 and BRCA2 to ovarian cancer. Mol Oncol. 2009;3:138-150.  https://doi.org/10.1016/j.molonc.2009.02.001
  42. Berchuck, A, Heron KA, Carney M, Lancaster J, Fraser EG, Vinson VL, Deffenbaugh A, Miron A, Marks J, Futreal PA, Frank T. Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res. 1998;4:2433-2437.
  43. Foster KA, Harrington P, Kerr J, Russell P, Dicioccio R, Scott I, Jacobs I, Chenevix-Trench G, Ponder B, Gayther S. Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res. 1996;56:3622-3625.
  44. Cunningham JM, Cicek MS, Larson NB, Davila J, Wang C, Larson M, Song H, Dicks E, Harrington P, Wick M, Winterhoff B, Hamidi H, Konecny G, Chien J, Bibikova M, Fan J-B, Kalli K, Lindor N, Fridley B, Pharoah P, Goode E. Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status. Scientific Reports. 2014;4:4026. https://doi.org/10.1038/srep04026
  45. Gates MA, Rosner BA, Hecht JL, Tworoger SS. Risk factors for epithelial ovarian cancer by histological subtype. Am J Epidemiol. 2010;171:45-53.  https://doi.org/10.1093/aje/kwp314
  46. Sergentanis T, Diamantaras A-A, Perlepe C, Kanavidis P, Skalkidou A, Petridou E. IVF and breast cancer: a systematic review and meta-analysis. Hum Reprod Update. 2014;20:1:106-123.  https://doi.org/10.1093/humupd/dmt034
  47. Irvin S, Weiderpass E, Stanczyk F, Brinton L, Trabert B, Langseth H, Wentzensen N. Association of anti-mullerian hormone, follicle-stimulating hormone and inhibin B with risk of ovarian cancer in the janus serum bank. Cancer Epidemiol Biomarkers Prev. 2020;29:3:636-642.  https://doi.org/10.1158/1055-9965.EPI-19-0675

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.